LUKASZ SZARPAK to Percutaneous Coronary Intervention
This is a "connection" page, showing publications LUKASZ SZARPAK has written about Percutaneous Coronary Intervention.
Connection Strength
1.612
-
Safety and efficacy of clopidogrel versus ticagrelor in acute coronary syndrome in the prehospital setting. Am J Emerg Med. 2022 06; 56:351-352.
Score: 0.566
-
Efficacy and safety of prasugrel and clopidogrel in st-segment elevation myocardial infarction in prehospital setting. Am J Emerg Med. 2022 03; 53:254-255.
Score: 0.550
-
Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint. Cardiol J. 2025; 32(2):189-194.
Score: 0.180
-
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpoint. Cardiol J. 2025; 32(1):83-89.
Score: 0.178
-
Tirofiban in emergency conditions. Am J Emerg Med. 2022 01; 51:422-423.
Score: 0.137